Inventor · disambiguated record
Brian Dolinski
Also filed as: DOLINSKI BRIAN · DOLINSKI BRIAN M
5 granted patents·8 pending applications·44 citations·filing 2015–2024
79Inventor score
Top patents by PatentIndex Score
13 records- 0193US11666642B2PDE5 compositions and methods for immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2022·Granted Jun 6, 2023·9 cites·26 claims
- 0292US11241485B2PDE5 compositions and methods for immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2018·Granted Feb 8, 2022·11 cites·26 claims
- 0390US11446398B2Regulated biocircuit systemsOBSIDIAN THERAPEUTICS INC·Filed 2017·Granted Sep 20, 2022·21 cites·7 claims
- 0487US12104178B2DHFR tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2021·Granted Oct 1, 2024·1 cites·7 claims
- 0584US11629340B2DHFR tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2019·Granted Apr 18, 2023·2 cites·29 claims
- 0677US2024401004A1Dhfr tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0758US2023233608A1Regulated biocircuit systemsOBSIDIAN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0849US2022175781A1Cd40l compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0948US2021386788A1Er tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1046US2023092895A1Tandem cd19 car-based compositions and methods for immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1145US2022403001A1Pde5 derived regulatory constructs and methods of use in immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1245US2023026259A1Ca2 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1331US2017362324A1Humanized anti-alpha v beta 5 antibodies and uses thereofBIOGEN MA INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian Dolinski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →